Pathstone Holdings, LLC Spring Works Therapeutics, Inc. Transaction History

Pathstone Holdings, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$34.43 - $46.99 $272,685 - $372,160	-7,920 Reduced 19.21%	33,301 $1.56 Million
Q1 2025 May 15, 2025	BUY	$32.5 - $59.93 $765,180 - $1.41 Million	23,544 Added 133.19%	41,221 $1.82 Million
Q4 2024 Feb 14, 2025	BUY	$28.61 - $42.55 $38,509 - $57,272	1,346 Added 8.24%	17,677 $638,000
Q3 2024 Nov 07, 2024	BUY	$32.04 - $42.76 $161,481 - $215,510	5,040 Added 44.64%	16,331 $523,000
Q2 2024 Aug 14, 2024	BUY	$36.06 - $47.62 $407,153 - $537,677	11,291 New	11,291 $425,000

7.36M

23K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.93B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Holdings, LLC with notifications on news.